Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma - Top-Institutions - MDSpire

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

  • By

  • Lin Zhu

  • Die Zhang

  • Jie Chen

  • Wei Qian

  • Peiyao Liu

  • Chunying Shen

  • Tingting Xu

  • Xin Zhou

  • Xueguan Lu

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, China

    Key Differentiators

    • Oncology

  • #2

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #3

    The Ohio State University Comprehensive Cancer Center
    The Ohio State University Comprehensive Cancer Center

    Columbus, Ohio

    Key Differentiators

    • Oncology

  • #4

    University Paris Cité
    University Paris Cité

    Paris, France

    Key Differentiators

    • Oncology

  • #5

    INSERM U970
    INSERM U970

    Paris, France

    Key Differentiators

    • Oncology

Original Source(s)

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

  • by Lin Zhu, Die Zhang, Jie Chen, Wei Qian, Peiyao Liu, Chunying Shen, Tingting Xu, Xin Zhou, Xueguan Lu

  • June 11, 2026

Related Content

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis

Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib